Consulting JW

A boutique clinical development consulting company focused largely on oncology, with additional expertise in rare diseases.

Innovative Consulting Solutions Provided by cjw

Welcome to CJW

Experienced in all phases of clinical development.

Hematologic malignancies and solid tumors
Investigational agents include a diverse range of modalities such as small molecules and biologics, immuno-oncology, cell therapy and CART
Experienced in FDA and global regulatory interactions

Typical projects we get involved in:

Creating Clinical Development Plans

Provide expertise across disciplines to design and execute clinical trials

CMO and team members depending on the clients’ own capabilities and resourcing
Overseeing a CRO

Technical assessment in-licensing in opportunities
Writing clinical study protocols, briefing documents as well as other documents for clinical site and/or Health-Authority interactions

What we are not

We are not a CRO or a recruitment agency, but we provide team expertise that substitutes for or complements in house expertise. We often oversee the work of CROs.

Areas of Expertise

• CMO

• Medical Monitoring

• Regulatory Affairs

• Statistics

• Medical Writing

• Clinical Science

• Clinical Operations

• Pharmacovigilance

• Clinical QA

• Project Management

About CJW

Jackie Walling

Led by Jackie Walling MBChB PhD, an experienced oncology drug developer with > 30 years’ experience. Jackie held key leadership positions that led to the successful approvals of gemcitabine, pemetrexed and relugolix. She has held multiple fractional CMO positions.

Our Team

Team members typically have 15 to 30 years experience in oncology with a proven track record of delivering quality work on time and who successfully collaborate in complex team environments. We only hire based on personal collaborations /recommendations.

When and why do we get hired?

• Often by a Sponsor at preIND stage not yet ready to build their own internal expertise and/or needing expertise in a position where a full-time person isn’t yet justified, or when a position is vacant, for example an interim CMO.

• When a Sponsor needs expert help on specific projects such as generating clinical development plans, FDA interactions including meetings, or making a technical assessment of an in-licensing opportunity, or if there is a clinical development concern such as a safety signal for which the internal team needs additional expertise.

CJW: Your partner in all phases of clinical development

Contact us for more information:

To help us provide a clear and informed response tailored to your clinical or organizational needs, please include the following details in your email:

Type of organization
Therapeutic area or indication of interest (Rare Disease or Oncology)
Clinical trial phase
(e.g., preclinical, Phase I–III, post‑marketing)
Specific services you are seeking
(e.g., protocol development, site selection, regulatory strategy, medical monitoring, data review)
Timeline or urgency of support needed
Geographic regions involved
(e.g., US, EU, APAC, global)

Contact Us at info@consultingjw.com